ClaritevCTEV +1.43%57 Gross Margin % is 66.97% as of Mar. 2026, which is 11% below its 10-year median of 75.18. GuruFocus rates CTEV with a GF Score™ of 57/100 and a GF Value™ of $31.33 (Fairly Valued). The stock has 6 warning signs investors should review. Among 631 Healthcare Providers & Services companies, Claritev ranks better than 75.91% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. Claritev's Gross Profit for the
three
months ended in Mar. 2026 was $163.9 Mil. Claritev's Revenue for the
three
months ended in Mar. 2026 was $244.7 Mil. Therefore, Claritev's Gross Margin % for the quarter that ended in Mar. 2026 was 66.97%.
Warning Sign:
Claritev Corp gross margin has been in long-term decline. The average rate of decline per year is -2.1%.
The historical rank and industry rank for Claritev's Gross Margin % or its related term are showing as below:
CTEV'
s Gross Margin % Range Over the Past 10 Years
Min: 66.02 Med: 75.18 Max: 85.64
Current: 67.28
During the past 8 years, the highestGross Margin % of Claritev was 85.64%. The lowest was 66.02%. And the median was 75.18%.
CTEV's Gross Margin % is ranked better than 75.91% of 631
companies
in the Healthcare Providers & Services industry
Industry Median: 40.09
vs CTEV: 67.28
Claritev had a gross margin of 66.97% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Claritev was -2.10% per year.
Claritev (NYSE:CTEV) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Claritev had a gross margin of 66.97% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Claritev Gross Margin % Related Terms
Claritev Gross Margin % Historical Data
* Premium members only.
The historical data trend for Claritev's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Claritev's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Claritev Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Claritev's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Claritev's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Claritev (CTEV) has a Gross Margin % of 66.97% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Claritev and its competitors. This is 11% below median its historical median of 75.18. Over the past decade, Claritev's Gross Margin % has ranged from 66.02 to 85.64. According to the industry distribution chart, Claritev ranks #152 out of 631 companies in the Healthcare Providers & Services industry, placing it in the top 24.1%.
Is Claritev's Gross Margin % too high?
Claritev's current Gross Margin % of 66.97% is 11% below median its 10-year median of 75.18. Over the past 10 years, this metric has ranged from a low of 66.02 to a high of 85.64. The Healthcare Providers & Services industry median Gross Margin % is 40.09. Claritev's value of 66.97% is 67% above this industry median. Based on the distribution chart, Claritev ranks #152 out of 631 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Claritev has a GF Score™ of 57/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Claritev's Gross Margin % compare to NRC and EVH?
According to the Healthcare Providers & Services industry distribution chart, Claritev ranks #152 out of 631 companies for Gross Margin %. This places Claritev in the top 24% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 40.09. Claritev's value of 66.97% is 67% above this benchmark. Historically, Claritev's own Gross Margin % has ranged from 66.02 to 85.64 over the past decade. While the company's 10-year median is 75.18 vs. the industry median of 40.09, Claritev has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.09, based on 631 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Claritev's current Gross Margin % of 66.97% is 67% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Claritev and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Claritev's current Gross Margin % is 66.97%, which is 11% below median its own 10-year median of 75.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Claritev stock overvalued right now?
Based on GuruFocus' analysis, Claritev (CTEV) is currently considered Fairly Valued. The stock's GF Value™ is $31.33, compared to a current price of $30.49 — trading 2.7% below its estimated fair value. The current Gross Margin % is 66.97%, which is 11% below median its 10-year median of 75.18 and 67% above the Healthcare Providers & Services industry median of 40.09. Claritev's overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Claritev (CTEV), the current Gross Margin % is 66.97% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Claritev (CTEV) Overvalued in 2026?
Based on GuruFocus' analysis, Claritev stock appears to be undervalued.
The current stock price of $30.49 is trading 2.7% below its estimated GF Value™ of $31.33.
GuruFocus considers Claritev to be Fairly Valued.
Key valuation signals for CTEV:
Gross Margin %: 66.97% (11% below median its 10-year median of 75.18)
GF Value™: $31.33 vs. price of $30.49 (2.7% below fair value)
Industry Position: 67% above the Healthcare Providers & Services median (#152 of 631)
No single metric tells the full story. See the CTEV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The company's focus is on being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.
57GF Score
Get the complete analysis for CTEV
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CTEV has been successfully added to your 
